Page 2 - Best Allogenic bone marrow transplantation from a related donor Allogenic bone marrow transplantation from a related donor: TOP 71 doctors

Dr. Fredi Aviv brings over 34 years of experience of specialized oncohematology experience at Sourasky Medical Center (Ichilov Clinic).

• Expert in allogenic bone marrow transplantation from related donors
• Extensive background in treating complex blood disorders
• Practices at one of Israel's leading medical centers

Dr. Litleaungdej is a hematologist specializing in allogenic bone marrow transplants, with training from Thammasat University Hospital.

• Graduated with honors from Naresuan University Hospital
• Completed hematology fellowship at Thammasat University
• Pioneer hematologist at Huahin Hospital
• Co-author of research on cancer-associated venous thromboembolism

Trained at Duke University and Fred Hutchinson Cancer Research Center – Dr. Gulsan specializes in allogenic bone marrow transplantation with a focus on related donor cases.

• Founder and manager of Gazi University's Adult Stem Cell Transplant Unit
• Head of Hematology Department at Gazi University
• Member of the Turkish Hematology Association

Leading expert in bone marrow transplantation with 36 years of experience at San Raffaele – heads their renowned Hematology and BMT Unit.

• Principal investigator for clinical trials in cell and gene therapy
• Published 180+ papers on hematological treatments
• Member of the European Blood and Marrow Transplantation Group
• Specialized in both hematology and rheumatology

Dr. Dror Levin specializes in pediatric hematology and oncology, with a focus on bone marrow transplantation and sarcoma treatment at Sourasky Medical Center.

• Director of children's hematology oncology department at Sourasky Medical Center
• Specialized in pediatric hematology and oncology at Schneider Children's Medical Center
• Member of the Israel association for pediatric hemato-oncology (ISPHO)
• Studied bone and soft tissue oncology at Rizzoli Orthopaedic Institute in Italy

Dr. Yair specializes in hematology with a focus on chronic lymphocytic leukemia – recognized with multiple awards for his research and clinical excellence.

• Recipient of the Young Investigator Research Prize and Klitzberg Oncology Award
• Member of both Israeli and American Hematology Associations
• Trained at top medical centers including Tel Aviv Medical Center
• Published extensively in hematology research

Dr. Seehirunwong specializes in interpreting medical imaging tests and consulting on patient care at Intrarat Hospital.

• Doctor of Medicine from Prince of Songkla University
• Certified in Diagnostic Radiology from Prince of Songkla University
• Performs and directs imaging tests, including radiation oncology and interventional radiology
• Consults with healthcare providers to choose the right imaging tests

Professor Hasan Atilla Ozkan specializes in allogeneic bone marrow transplants at VM Medical Park Pendik Hospital, with extensive training and leadership in hematology.

• Board-certified hematologist with subspecialty in bone marrow transplantation
• Current president of the Turkish Therapeutic Apheresis Association
• Trained at Uludağ University and certified by EBMT for stem cell transplantation
• Professor at Yeditepe University Faculty of Medicine

Dr. Alemdar specializes in allogenic bone marrow transplants at Medical Park Antalya Hospital Complex, with extensive training in medical oncology and internal medicine.

• Trained at Akdeniz University Faculty of Medicine
• Specializes in medical oncology and internal medicine
• Works at a modern, well-equipped hospital complex

Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.

She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.

Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.

Dr. Mahmoud M. El Zembely is a pediatric oncologist and malignant hematologist. He manages acute lymphoblastic leukemia, acute myeloid leukemia, and chronic myeloid leukemia. He treats Hodgkin and non‑Hodgkin lymphomas, nephroblastoma, neuroblastoma, and bone and liver tumors. His work includes gonadal and extragonadal germ cell tumors, rhabdomyosarcoma, and non‑rhabdomyosarcoma soft tissue sarcomas. He also cares for rare cancers and survivorship.

Accreditations: M.B.B.Ch, Assiut University, 2006. Master’s in Pediatric Oncology and Malignant Hematology, 2011. Clinical fellowship in pediatric bone marrow transplantation, Seattle Cancer Care Alliance, 2015–2017. Doctorate, 2020.

Roles: South Egypt Cancer Institute–Assiut University: Pediatric Oncology, 2008–2012. Assistant Lecturer, 2012–2019. Lecturer, 2020–2024. Shefa Al‑Orman Cancer Center, Luxor: Head of Pediatric Oncology, 2020–present.

Dr. Danylesko specializes in allogenic bone marrow transplantation at Sheba Medical Center, one of Israel's top hospitals.

• Experienced in handling related donor transplants
• Works at a leading center for hematologic malignancies
• Follows international transplantation protocols

Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.

He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.

He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.

Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.

He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.

He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).

Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.

She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.

Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.